Skip to main content

FDA recall, , Moderate risk

Contego Medical Neuroguard IEP Carotid Stent and Balloon System

The Neuroguard IEP 3 in 1 Carotid Stent and Post-Dilation Balloon System may fail to open its integrated filter.

What happened

Contego Medical, Inc., of Raleigh, North Carolina, recalled the Neuroguard IEP 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System) on June 29, 2026, because a wire-to-filter-bond issue may cause the integrated filter to fail to open following sheath retraction, potentially resulting in loss of intended integrated embolic protection during a procedure.

The FDA added the recall to its Enforcement Report on August 6, 2026. The system was distributed in the states of IL, FL, NC, WI, KY, AL, VA, DE, NJ, PA, IN, MI, CA.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Product details

    Neuroguard IEP 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System), REF: NG-0630-140-2, NG-0640-140-2, NG-0730-140-2, NG-0740-140-2, NG-NV-6-30, NG-NV-6-40, NG-NV-7-30, NG-NV-7-40

    UDI-DI
    • 00851616007583
    • 00851616007590
    • 00851616007606
    • 00851616007613
    • 00851616007644
    • 00851616007651
    • 00851616007637
    • 00851616007620
    Lot code
    • NG-0630-140-2
    • Z2460578D
    • Z2460740B
    • Z2460872C
    • Z2460909F
    • Z2460948D
    • Z2460957Q

Recall details

Company began the recall
Company
Contego Medical, IncRaleigh, North Carolina
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99353
Recall number
Z-2911-2026

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)